Alpha-1 antitrypsin deficiency.
Primhak
R A
RA
Institute of Child Health, University of Sheffield, Sheffield Children's Hospital, Western Bank, Sheffield S10 2TH, UK. r.a.primhak@sheffield.ac.uk
Tanner
M S
MS
D000328:Adult; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001942:Breast Feeding / Q000009:adverse effects; D002648:Child; D004646:Emphysema / Q000209:etiology; D015316:Genetic Therapy; D006579:Heterozygote; D006801:Humans; D007223:Infant; D008111:Liver Function Tests; D016031:Liver Transplantation; D051379:Mice; D010641:Phenotype; D010654:Phenylbutyrates / Q000627:therapeutic use; D011379:Prognosis; D012907:Smoking / Q000009:adverse effects; D014812:Vitamin K / Q000008:administration & dosage; D000515:alpha 1-Antitrypsin / Q000235:genetics / Q000627:therapeutic use; D019896:alpha 1-Antitrypsin Deficiency / Q000150:complications* / Q000175:diagnosis / Q000628:therapy
D000970:Antineoplastic Agents; D010654:Phenylbutyrates; D000515:alpha 1-Antitrypsin; D014812:Vitamin K; C075773:4-phenylbutyric acid